X, H., YY, S., YR, Q., H, C., TT, P., SS, Z., . . . QH, M. (2026). ApoE-directed CpG nano-immunoadjuvant ameliorates Alzheimer's-like pathology in mice. Journal of controlled release : official journal of the Controlled Release Society, 392, 114687. https://doi.org/10.1016/j.jconrel.2026.114687
Chicago Style (17th ed.) CitationX, Huang, et al. "ApoE-directed CpG Nano-immunoadjuvant Ameliorates Alzheimer's-like Pathology in Mice." Journal of Controlled Release : Official Journal of the Controlled Release Society 392 (2026): 114687. https://doi.org/10.1016/j.jconrel.2026.114687.
MLA (9th ed.) CitationX, Huang, et al. "ApoE-directed CpG Nano-immunoadjuvant Ameliorates Alzheimer's-like Pathology in Mice." Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 392, 2026, p. 114687, https://doi.org/10.1016/j.jconrel.2026.114687.